Trial Informatics

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Trial Informatics - overview

Established

2020

Location

Seoul, -, South Korea

Primary Industry

Healthcare IT

About

Based in Seoul, South Korea, and founded in 2020, Trial Informatics operates as a health-tech company that provides digital health technologies to recreate clinical trial data. In April 2022, Trial Informatics raised seed funding from Korea Tech Incubator for Startups, being selected for Accelerator Investment-Driven Tech Incubator Program. As of November 2022, Kyung Won Kim is the Chief Executive Officer (CEO) of the company. Trial Informatics provides services that improve the accuracy and speed of clinical drug ability review by analyzing image data such as patient medical images, biosignal information, pathology information, and human-derived specimen information, with a focus on anticancer drug clinical trials.


Furthermore, the company offers two products: ImageTrial, which uses image data management during clinical trials for data warehousing, and OncoTrial Board, which uses medical monitoring during clinical trials using data from previous trials.


Current Investors

Korea Tech Incubator for Startup

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Medical Software

Website

www.trialinformatics.com

Verticals

Cloud Computing, HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.